Answer
Taking Delstrigo with rifampicin is contraindicated because rifampicin strongly induces CYP3A enzymes, which is expected to significantly decrease doravirine plasma concentrations and may reduce Delstrigo’s effectiveness.
Sources for this answer
- Delstrigo 100 mg /300 mg /245 mg film-coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.3 Contraindications · Version 16Document updated
Sources checked